Showing results (551-560 of 672) with videos related to

Sort By:
Pageof 68
European Journal of Medicinal Chemistry|May 12, 2012
Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitorsShuang-Xi Gu, Zhi-Ming Li, Xiao-Dong Ma, et al.
Chemical Communications (Cambridge, England)|December 24, 2019
Direct arylation of C<sub>60</sub>Cl<sub>6</sub> and C<sub>70</sub>Cl<sub>8</sub> with carboxylic acids: a synthetic avenue to water-soluble fullerene derivatives with promising antiviral activityOlga A Kraevaya, Alexander S Peregudov, Ivan A Godovikov, et al.
Journal of Virology|June 29, 2004
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RTJoeri Auwerx, Miguel Stevens, An R Van Rompay, et al.
Journal of Medicinal Chemistry|March 4, 2011
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamideGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Antiviral Research|May 6, 2006
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibioticsJan Balzarini, Els Keyaerts, Leen Vijgen, et al.
Molecular Pharmacology|June 18, 2005
The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide AJoeri Auwerx, Fátima Rodríguez-Barrios, Francesca Ceccherini-Silberstein, et al.
Antiviral Research|April 20, 2011
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)Geoffrey Férir, Kurt Vermeire, Dana Huskens, et al.
Nuclear Medicine and Biology|March 27, 2007
Synthesis and evaluation of a (99m)Tc-MAMA-propyl-thymidine complex as a potential probe for in vivo visualization of tumor cell proliferation with SPECTSofie Celen, Tjibbe de Groot, Jan Balzarini, et al.
The Journal of Antibiotics|January 10, 2009
Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activityAnna N Tevyashova, Eugenia N Olsufyeva, Eugenia N Zbarsky, et al.
Biochemical Pharmacology|April 10, 2017
Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes virusesJan Balzarini, Michael Menni, Kalyan Das, et al.
Pageof 68